Prostate cancer
Conditions
Interventions
Gold Standard:Clinical and/or pathological diagnosis
Index test:Molecular genetics testing
Sponsors
Fudan University Shanghai Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ?Age >= 18 years old; ?Urine sample >= 50mL; ?One of the following conditions must be met: 1) Suspicious patients with elevated PSA, positive DRE or imaging tests, who are proposed to undergo prostate biopsy; 2) Patients with definitive diagnosis of prostate cancer by prostate biopsy, who are proposed to undergo prostate cancer surgery and or endocrine therapy or radiotherapy; 3) Patients clinically diagnosed with benign urinary diseases, including: benign prostatic hyperplasia, prostatitis, urinary stones, renal cysts, ureteral stenosis, urethral stenosis, urethral hypospadias, urinary tract infections, glandular cystitis, and other benign diseases of the urinary system; 4) Patients with other tumors that are clinically or pathologically diagnosed as non-prostate cancer, including bladder cancer, renal cancer, ureteral cancer, and renal pelvis cancer, etc.
Exclusion criteria
Exclusion criteria: ? Patients who have received prior transurethral resection or enucleation of the prostate, prostate radiation therapy; ? Patients who have received endocrine treatment or taking 5a-reductase inhibitors within 6 months; ? Any other condition deemed unsuitable for inclusion by researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;Accuracy; | — |
Countries
China
Contacts
Public ContactDingwei Ye
Fudan University Shanghai Cancer Center
Outcome results
None listed